Coexistence of metastatic neuroendocrine carcinoma of the uterine cervix with human immunodeficiency virus infection

J. Balega, Thomas Ulbright, K. Y. Look

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Women now constitute 28% of new cases of human immunodeficiency virus (HIV) infection. Cervical cancer in HIV-infected women has a high recurrence and death rate, as well as decreased intervals to recurrence and death. Neuroendocrine carcinomas of the cervix are characterized by a high frequency of early nodal and distant metastases. We present the first report of a neuroendocrine carcinoma of the cervix in an HIV-positive patient. A 28 year old with a 9-year history of HIV succumbed to metastatic neuroendocrine carcinoma of the cervix 5 months after diagnosis. Given the aggressive nature of the cell type, an extended metastatic workup should be considered prior to surgery. The immune suppression present in HIV-positive patients with neuroendocrine cervical carcinoma may make such a workup particularly crucial, such that surgery is offered only to those who can be expected to benefit.

Original languageEnglish
Pages (from-to)334-337
Number of pages4
JournalInternational Journal of Gynecological Cancer
Volume11
Issue number4
DOIs
StatePublished - 2001

Fingerprint

Neuroendocrine Carcinoma
Virus Diseases
Cervix Uteri
HIV
Recurrence
Uterine Cervical Neoplasms
Neoplasm Metastasis
Mortality

Keywords

  • HIV
  • Neuroendocrine cervix cancer

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology
  • Cancer Research

Cite this

@article{7222c9013417478e89176031a8deaed2,
title = "Coexistence of metastatic neuroendocrine carcinoma of the uterine cervix with human immunodeficiency virus infection",
abstract = "Women now constitute 28{\%} of new cases of human immunodeficiency virus (HIV) infection. Cervical cancer in HIV-infected women has a high recurrence and death rate, as well as decreased intervals to recurrence and death. Neuroendocrine carcinomas of the cervix are characterized by a high frequency of early nodal and distant metastases. We present the first report of a neuroendocrine carcinoma of the cervix in an HIV-positive patient. A 28 year old with a 9-year history of HIV succumbed to metastatic neuroendocrine carcinoma of the cervix 5 months after diagnosis. Given the aggressive nature of the cell type, an extended metastatic workup should be considered prior to surgery. The immune suppression present in HIV-positive patients with neuroendocrine cervical carcinoma may make such a workup particularly crucial, such that surgery is offered only to those who can be expected to benefit.",
keywords = "HIV, Neuroendocrine cervix cancer",
author = "J. Balega and Thomas Ulbright and Look, {K. Y.}",
year = "2001",
doi = "10.1046/j.1525-1438.2001.011004334.x",
language = "English",
volume = "11",
pages = "334--337",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Coexistence of metastatic neuroendocrine carcinoma of the uterine cervix with human immunodeficiency virus infection

AU - Balega, J.

AU - Ulbright, Thomas

AU - Look, K. Y.

PY - 2001

Y1 - 2001

N2 - Women now constitute 28% of new cases of human immunodeficiency virus (HIV) infection. Cervical cancer in HIV-infected women has a high recurrence and death rate, as well as decreased intervals to recurrence and death. Neuroendocrine carcinomas of the cervix are characterized by a high frequency of early nodal and distant metastases. We present the first report of a neuroendocrine carcinoma of the cervix in an HIV-positive patient. A 28 year old with a 9-year history of HIV succumbed to metastatic neuroendocrine carcinoma of the cervix 5 months after diagnosis. Given the aggressive nature of the cell type, an extended metastatic workup should be considered prior to surgery. The immune suppression present in HIV-positive patients with neuroendocrine cervical carcinoma may make such a workup particularly crucial, such that surgery is offered only to those who can be expected to benefit.

AB - Women now constitute 28% of new cases of human immunodeficiency virus (HIV) infection. Cervical cancer in HIV-infected women has a high recurrence and death rate, as well as decreased intervals to recurrence and death. Neuroendocrine carcinomas of the cervix are characterized by a high frequency of early nodal and distant metastases. We present the first report of a neuroendocrine carcinoma of the cervix in an HIV-positive patient. A 28 year old with a 9-year history of HIV succumbed to metastatic neuroendocrine carcinoma of the cervix 5 months after diagnosis. Given the aggressive nature of the cell type, an extended metastatic workup should be considered prior to surgery. The immune suppression present in HIV-positive patients with neuroendocrine cervical carcinoma may make such a workup particularly crucial, such that surgery is offered only to those who can be expected to benefit.

KW - HIV

KW - Neuroendocrine cervix cancer

UR - http://www.scopus.com/inward/record.url?scp=0034886504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034886504&partnerID=8YFLogxK

U2 - 10.1046/j.1525-1438.2001.011004334.x

DO - 10.1046/j.1525-1438.2001.011004334.x

M3 - Article

VL - 11

SP - 334

EP - 337

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 4

ER -